Chronic Pulmonary Hypertension Diagnostic Market is segmented By Drug Class (Endothelin Receptor Antagonists, Phosphodiesterase-5 Inhibitors, Prostacy....
The major players operating in the chronic pulmonary hypertension diagnostic market include Johnson & Johnson (Actelion Pharmaceuticals), Bayer AG, United Therapeutics Corporation, GlaxoSmithKline plc, Pfizer Inc., Eli Lilly and Company, and Gilead Sciences, Inc.
Chronic Pulmonary Hypertension Diagnostic Market